The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra

The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma is a phase 2, interventional study registered as NCT06266832 by Sir Run Run Shaw Hospital, with a registry enrolment figure of 30 participants, started 2024-01-01 and due to reach its primary completion in 2025-01-01. Interventions recorded: Adebrelimab; Oxaliplatin; Capecitabine; Short-course Radiation; Biopsy. Conditions listed: Rectal Adenocarcinoma. Primary outcome: Organ retention rate. Colorectal eligibility wording from the registry: "Diagnosed by digital rectal examination, colonoscopy, and high-resolution MRI of the pelvis, the tumor is less than or equal to 5 cm from the anus". Sites: China. No results are recorded here; the registry entry is the source.